CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-09-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-09-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-08-16 | Bencich John CEO | Grant or award | +3,059 | $4.37 | $13K | 14,920 |
| 2022-08-16 | JACOBS CINDY President & CMO | Grant or award | +1,817 | $4.37 | $8K | 3,931 |
| 2022-08-16 | Wan Jerry Principal Accounting Officer | Grant or award | +2,827 | $4.37 | $12K | 3,502 |
| 2022-08-16 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −266 | $4.37 | $1K | 3,236 |
| 2022-08-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-08-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-08-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-07-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +45,137.38 | 7,782,973.79 | ||
| 2022-07-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +22,568.69 | 3,891,486.89 | ||
| 2022-07-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +22,568.69 | 3,891,486.89 | ||
| 2022-06-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +44,875.6 | 7,737,836.41 | ||
| 2022-06-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +22,437.8 | 3,868,918.2 | ||
| 2022-06-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +22,437.8 | 3,868,918.2 | ||
| 2022-05-31 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +4,400 | 4,400 | ||
| 2022-05-31 | Martell Bridget A Director | Grant or award · Stock Option (right to buy) | +4,400 | 4,400 | ||
| 2022-05-31 | MATTINGLY MARTIN A Director | Grant or award · Stock Option (right to buy) | +4,400 | 4,400 | ||
| 2022-05-31 | MOYES JAY M Director | Grant or award · Stock Option (right to buy) | +4,400 | 4,400 |
Page 9 of 36 · 715 trades